Latent form of transforming growth factor-beta 1 acts as a potent growth inhibitor on a human erythroleukemia cell line

Biochem Biophys Res Commun. 1990 Feb 28;167(1):27-32. doi: 10.1016/0006-291x(90)91725-8.

Abstract

Recombinant latent form of transforming growth factor-beta 1 (L-TGF-beta 1) is activated by various chemical treatments, including acidification and heating. However, cellular mechanisms that release transforming growth factor-beta (TGF-beta) in an active form have not been fully elucidated. Investigated herein are the effects of L-TGF-beta 1 on various leukemic cell lines. Heat-activated L-TGF-beta 1 inhibited colony formation of U937, KG-1 and HL-60, whereas untreated L-TGF-beta 1 had only a marginal effect on these cells. In contrast, colony formation of human erythroleukemia cell line (HEL) was markedly inhibited by both heat-activated and untreated L-TGF-beta 1. In vitro incubation of L-TGF-beta 1 with HEL cells did not release the active form in the culture supernatants. These results suggest that HEL cells are capable of activating L-TGF-beta 1, but only in a cell-associated manner. Since HEL cells produce L-TGF-beta 1, it may act as an autocrine negative growth factor on these cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carnivora
  • Cells, Cultured
  • Hot Temperature
  • Humans
  • Hydrogen-Ion Concentration
  • Leukemia, Erythroblastic, Acute / pathology*
  • Recombinant Proteins / pharmacology
  • Transforming Growth Factors / pharmacology*
  • Tumor Cells, Cultured / drug effects*

Substances

  • Recombinant Proteins
  • Transforming Growth Factors